Family: | Direxion Shares |
Name: | Direxion Daily S&P Biotech Bull 3x Shares |
Inception Date: | 28-May-2015 |
Termination Date: | |
Investment Objective: | The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015. |
Prospectus | |
Top 10 Holdings | ||
Derivatives offset | -238.6168% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 48.1640% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 41.7548% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 36.0655% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 34.3704% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 31.0291% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 24.5163% | |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 22.7168% | |
DREYFUS GOVT CASH MAN INS | 15.4391% | |
GOLDMAN FINL SQ TRSRY INST 506 | 12.6210% | |
Top 10 Holdings Weight: | 28.1% |
Number of Holdings: | 149 |
Shares Outstanding: | 9,974,486 |
Total Net Assets: | 886,033,600 |
NAV: | 88.88 |
Net Expense Ratio: | 0.95% |
Asset Class: | Equities (Stocks) |
Developed or Emerging: | Developed Market Funds |
Country: | US |
Region: | |
Strategy: | |
Currency: | |
Commodity: | |
Sector: | Healthcare |
Industry: | Biotech |
Dividend Type: | |
Tax Exempt State: | |
Maturity Duration: | |
Market Cap: | Broad Market / Multi-Cap |
Credit Quality: | |
Mortgage Bond Types: | |
Bond Type: | |
Gov't Bond Types: | |
Reit Type: | |
Leverage Direction/Factor: | Leveraged (3x) |
Is Currency Hedged: | No |
US or Ex-US: | Domestic |